Buyout bid made for Warner Chilcott

10/26/2004 | Wall Street Journal, The

Warner Chilcott, manufacturer of estrogen-replacement therapies and acne drugs, confirmed it has been approached by one of three financial outfits with apparent plans to buy the company, but would not identify the suitor. Since three are said to be interested, the idea of an auction for the company was developing, and a source said Goldman Sachs Capital Partners is the group that made the approach.

View Full Article in:

Wall Street Journal, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ